LEX-211 (FARES-II): a phase 3, prospective, active-control randomised study of four-factor prothrombin complex concentrate versus frozen plasma in bleeding adult cardiac surgery patients - ISTH Congress Abstracts
Utility of 4-Factor Prothrombin Complex Concentrate in Trauma and Acute-Care Surgical Patients
Vitamin K–dependent factors that are replenished with the use of... | Download Scientific Diagram
Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage | SpringerLink
Ken Dodd, MD on Twitter: "Fixed-Dosing of 1,500 units of the four-factor prothrombin complex concentrate Kcenta (compared to variable dosing) 1. Effectively corrects INR < 2.0 2. Decreases time to reversal 3.
Prothrombin Complex Concentrate (PCC) Market boosted at
PDF] Activated prothrombin complex concentrates for the reversal of anticoagulant-associated coagulopathy. | Semantic Scholar
Composition per vial of prothrombin complex concentrate 500 units 1... | Download Table
Infographics - Australia and New Zealand Prothrombin Complex Concentrate Market
Kcentra Approved for Urgent Reversal of Warfarin in Emergency Surgery Setting - MPR
Prothrombin Complex Concentrate for Critical Bleeding | Semantic Scholar
Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding | Circulation
Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting. - Abstract - Europe PMC
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial - The Lancet Neurology
What are the different types of prothrombin complex concentrates (PCCs)? • The Blood Project
Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study | BMC Emergency Medicine | Full Text
The benefit of prothrombin complex concentrate in decreasing neurological deterioration in patients with warfarin-associated intracerebral haemorrhage | HKMJ
Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models | PLOS ONE